Clinical Trial Update: Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing iStent implantation versus two unnamed ocular hypotensive agents in primary open-angle glaucoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• iStent

Snippet

Sponsor: Glaukos Corporation | Conditions: Eye Diseases, Glaucoma, Open-Angle | Phase 4 | Status: COMPLETED